Progetto Sigma Tau - GVHD
Evaluation of the pharmacological efficacy of the ST1959 synthesis molecule in mouse models of Graft Versus Host Disease (GVHD)
Acronym:
Sigma Tau - GVHD
Funding type:
Servizi alle Imprese
Programma:
Sigma-Tau Industrie Farmaceutiche Riunite SpA (now ALFASIGMA SpA)
Duration:
1 January 2006 to 31 December 2007
ENEA role:
Partner
Reference laboratory:
ENEA Project Leader:
Claudio Pioli
Other ENEA Personnel:
Francesca Nasta
Status:
Completed